AstraZeneca Can't Stop Mylan's Generic Nexium At Fed. Circ.

By Jeff Overley
August 3, 2015, 8:18 PM EDT

The Federal Circuit on Monday rejected AstraZeneca AB's attempt to block Mylan Inc.'s generic version of blockbuster heartburn drug Nexium, clearing the way for additional copycat competition for the popular "purple...

Already a subscriber? Click here to view full article